Clinical trial
Kaletra Sex/Gender Pharmacokinetics (PK) Study
NCT00148759 · Emory University, Other · Completed
Key facts
| NCT number | NCT00148759 |
|---|---|
| Title | Kaletra Sex/Gender Pharmacokinetics (PK) Study |
| Official title | A Switch From Twice Daily to Once Daily Lopinavir/Ritonavir: A 24-hour Pharmacokinetic Profile to Evaluate Sex Differences |
| Acronym | LPVGenderPK |
| Lead sponsor | Emory University, Other |
| Collaborators | Abbott Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | LPV/r |
| Enrollment | 23 |
| Start date | Jun 1, 2005 |
| Primary completion | Jan 1, 2007 |
| Completion | Jan 1, 2007 |
| First posted | Sep 8, 2005 |
| Last update posted | Dec 3, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: